AAS
NVAX icon

Ameritas Advisory Services’s Novavax NVAX Stock Holding History

Ameritas Advisory Services’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,550
Closed -$9.77K – 2657
2025
Q2 		$9.77K Buy
+1,550
New +$10.3K ﹤0.01% 2026
2023
Q2 		– Sell
-1,650
Closed -$13.3K – 1875
2023
Q1 		$13.3K Buy
+1,650
New +$15.2K ﹤0.01% 1797
2022
Q1 		– Sell
-1,920
Closed -$275K – 851
2021
Q4 		$275K Buy
+1,920
New +$330K 0.01% 672

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameritas Advisory Services's NVAX Position: Q3 2025 in Review

Ameritas Advisory Services sold out of Novavax (NVAX) in Q3 2025, closing a stake of 1,550 shares — an estimated $9.77K sold.

Ameritas Advisory Services first reported a position in NVAX in Q4 2021 and held it in 3 quarters. The position peaked at $275K in Q4 2021. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Ameritas Advisory Services reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 1,550 Novavax shares in Q3 2025, an estimated $9.77K.
  • Ameritas Advisory Services first reported a position in Novavax in Q4 2021 and held it in 3 quarters.
  • Ameritas Advisory Services's Novavax position peaked at $275K in Q4 2021.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Ameritas Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.